Marvell in talks to acquire Lumentum: Optical strategy fits, but financing and supply chain implications are challenging

How far have the talks progressed, and how is the market pricing the deal?

Bloomberg reported on 28 October that Marvell was in advanced talks to acquire Lumentum, with an announcement possible as early as the following week. The report did not disclose a deal value or payment method, and the news remained unconfirmed at the time.
At the time Bernstein wrote, Lumentum shares were up 13% and Marvell shares were down 8%. The firm assumed Lumentum would return to its closing price that day of $913.95 if the deal failed, an offer price of $1,190 per share, and completion in June 2027. On that basis, it calculated that the share price implied a roughly 48% probability of completion. The $1,190 offer corresponds to an acquisition premium of approximately 30%; it is an assumption used in the calculation, not a disclosed term.
Regulatory risk is another variable: Lumentum has substantial exposure to China, while consolidation of indium phosphide laser supply could present challenges for Chinese optical module manufacturers.

Bernstein believes the acquisition aligns with the direction of Marvell’s chief executive in advancing its optical business. Marvell previously acquired Celestial AI for 3.25 billion dollars; the deal was announced in December 2025 and completed on 2 February 2026.
Before any acquisition premium, Lumentum’s market capitalization was approximately 80 billion dollars, versus approximately 220 billion dollars for Marvell, making the deal enormous for the latter. Given Marvell’s net debt position and the market consensus forecast of 4.7 billion dollars in adjusted EBITDA for 2027, Bernstein believes all-cash financing is very likely infeasible.

Bernstein believes the acquisition could be earnings-accretive, depending on the terms: based on consensus earnings estimates for 2027–2029, Lumentum trades at a lower valuation multiple than Marvell; the firm also sees room for Lumentum’s earnings to exceed consensus.
The sources and scale of cost synergies remain unclear, and Bernstein expects Marvell may place greater emphasis on revenue synergies. The firm also notes that large transformational acquisitions often have a poor historical track record.
Bernstein maintains its outperform rating on Lumentum and its $1,220 price target. The target is based on its estimate of $35 in earnings per share for fiscal 2028, using a multiple of approximately 35 times.

Bernstein expects Coherent could gain market share in the near term: while the deal’s effects remain unclear, accelerator makers and hyperscale cloud providers may be reluctant to commit their purchases to Lumentum technology, and the acquired company’s attention may also shift toward completing and integrating the deal.
Ciena is both a Lumentum customer and a Marvell competitor. Ciena already faces supply constraints, and its supply of pump lasers could tighten further if Marvell is unwilling to supply a competitor. Cisco could face similar issues, though its in-house Acacia optical business could gain strategic recognition as a result.
Bernstein sees a relatively neutral impact on Celestica, Arista and Corning because they have greater flexibility in their choice of laser suppliers.